How to Cite
Abstract
Multiple primary malignancies in one person are considered to be a well-established phenomenon with a registered prevalence ranging from 0.73 to 11.7%. However, the synchronous category of these neoplasms, which is detected either simultaneously or within 6 months of the diagnosis of the first primary malignant tumor, is considered less common. At the same time, numerous risk factors contribute to the development of this clinical condition, such as genetic predisposition, immunosuppression, smoking, chemotherapy and ionizing radiation, however, the exact pathophysiology of this process remains completely unclear to date. In this brief literature review, an attempt is made to assess the probability of a combination of primary breast cancer with the simultaneous development of primary brain tumors.
References
Billroth T, Reimer G. Vorlesungen-Ein Handbuch fur Studierende und Artze, 14. Auflage, Berlin. 1889. Die Allgemeine chirurgische patologie und therapie In: G.Reimer (ed.) P. 908.
Moertel CG, Dockerty MB, Baggenstoss AH. Multiple Primary Malignant Neoplasms. II. Tumors of Different Tissues or Organs // Cancer. 1961;14:231–237. doi:10.1002/1097-0142(196103/04)14:2<231::AID-CNCR2820140203>3.0.CO;2-2. PMID: 13771653
Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study // Am J Cancer. 1932;16:1358–141.
Berg JW, Hutter RV. Breast cancer // Cancer. 1995;75(1 Suppl):257S–69S.
Green JR, Waggener JD, Kriegsfeld BA. Classification and incidence of neoplasms of the central nervous system // Adv Neurol. 1976;15:51–55.
Schoenberg B, Christine B, Whisnant J. Nervous system neoplasms and primary malignancies of other sites // Neurology. 1975;25(8):705–12. doi:10.1212/wnl.25.8.705. Corpus ID:38425062.
Poyhonen L, Heikkinen J, Vehkalahti I. Two different primary tumors of the brain in a patient with breast cancer // Eur J Nucl Med. 1979;4:483–484.
Gastaut JL, Koeppel MC, Alliez MB et al. Triple tumor association: breast cancer, meningioma and glioblastoma // Rev Neurol 1987;143:753–758.
Helseth A, Mørk SJ, Glattre E. Neoplasms of the central nervous system in Norway. V. Meningioma and cancer of other sites. An analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986 // APMIS. 1989;97(8):738–44.
Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women // Cancer. 2002;94:1626–1635.
Curtis RE, Freedman DM, Ron E et al. (2006) New Malignancies among Cancer Survivors: SEER Cancer Registries, 1973–2000. National Cancer Institute, Bethesda, MD, 9–14.
Hsu DW, Efird JT, Hadley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations // Journal of Neurosurgery. 1997:113–120. (10.3171/jns.1997.86.1.0113). PMID: 8988089. doi:10.3171/jns.1997.86.1.0113
Weiliang He, Ran Liu, Shao-Hua Yang, Yuan. Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas. 2015 Mar;26(3):293–300. PMID: 25535979. PMCID: PMC4310775. doi:10.1097/CAD.0000000000000197
Jianguang Ji, Jan Sundquist, Kristina Sundquist. Association of tamoxifen with meningioma: a population-based study in Sweden // Eur J Cancer Prev. 2016;25(1):29–33. PMID: 25642792. PMCID: PMC4885544. doi:10.1097/CEJ.0000000000000133
Kenneth Offit, Orna Levran, Brian Mullaney et al. Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia // Journal of the National Cancer Institute. 2003;95(20):1548–51. doi:10.1093/jnci/djg072
Bethke L, Murray A, Webb E et al. Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma // Journal of the National Cancer Institute. 2008;100(Issue 4):270–276. doi:10.1093/jnci/djn004
Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial low grade astrocytomas in adults // Neurosurgery. 1993;32:554–559.
Ogasawara K, Ogawa A, Shingai J et al. Synchronous multiple primary malignant tumors accompanied by glioblastoma // Neurol Med Chir (Tokyo). 1986;26:908–912.
Kobayashi S, Kojo N, Miyagi J et al. Results of the surgical treatment of metastatic brain tumors // No Shinkei Geka. 1985;13:825–830.
Friedman CD, Mccarthy JR. Multiple primary malignant neoplasms // IMJ Ill Med J. 1982;161:115–116.
Maluf FC, DeAngelis LM, Raizer JJ, Abrey LE. High-grade gliomas in patients with prior systemic malignancies // Cancer. 2002;94:3219–3224.
Piccirilli M, Salvati M, Bistazzoni S et al. Glioblastoma multiforme and breast cancer: report on 11 cases and clinico-pathological remarks // Tumori. 2005;91:256–260.
Zacharia BE, DiStefano N, Mader MM et al. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients // J Neurooncol. 2017;134(2):245–251. doi:10.1007/s11060-017-2512-y
Malkin D, Li FP, Strong LC et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms // Science. 1990;250:1233–1238.
Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer // Science. 1997;275:1943–1947.
Meriem Boukerroucha, Claire Josse, Karin Segers et al. BRCA1 germline mutation and glioblastoma development: report of cases. BMC // Cancer. 2015;15:181. PMID: 25880076. PMCID: PMC4377178. doi:10.1186/s12885-015-1205-1
Raufi A, Alsharedi M, Khelfa Y, Tirona M. Bilateral Triple-Negative Invasive Breast Cancer with a BRCA2 Mutation, and Glioblastoma: A Case Report and Literature Review // J Breast Cancer. 2017;20(1):108–111. doi:10.4048/jbc.2017.20.1.108. Epub 2017 Mar 24. PMID: 28382102.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2021